First American Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$556K Sell
23,110
-67
-0.3% -$1.75K 0.03% 168
2026
Q1
$651K Buy
23,177
+352
+2% +$9.37K 0.04% 151
2025
Q4
$568K Buy
22,825
+79
+0.3% +$1.99K 0.03% 152
2025
Q3
$580K Buy
22,746
+700
+3% +$17.3K 0.04% 150
2025
Q2
$534K Hold
22,046
0.04% 145
2025
Q1
$559K Sell
22,046
-600
-3% -$15.7K 0.04% 140
2024
Q4
$601K Buy
22,646
+274
+1% +$7.43K 0.04% 139
2024
Q3
$647K Buy
22,372
+13
+0.1% +$379 0.05% 138
2024
Q2
$626K Buy
22,359
+689
+3% +$19K 0.05% 134
2024
Q1
$601K Sell
21,670
-741
-3% -$20.6K 0.05% 138
2023
Q4
$645K Sell
22,411
-1,541
-6% -$46.6K 0.05% 137
2023
Q3
$794K Sell
23,952
-207
-0.9% -$7.32K 0.07% 132
2023
Q2
$886K Sell
24,159
-685
-3% -$26.7K 0.08% 130
2023
Q1
$1.01M Sell
24,844
-2,782
-10% -$120K 0.09% 125
2022
Q4
$1.42M Buy
27,626
+970
+4% +$46.5K 0.14% 108
2022
Q3
$1.17M Buy
26,656
+417
+2% +$20.3K 0.12% 110
2022
Q2
$1.38M Hold
26,239
0.14% 108
2022
Q1
$1.36M Hold
26,239
0.12% 118
2021
Q4
$1.55M Sell
26,239
-530
-2% -$26.3K 0.08% 157
2021
Q3
$1.15M Sell
26,769
-1,076
-4% -$47.7K 0.07% 171
2021
Q2
$1.09M Sell
27,845
-67,879
-71% -$2.64M 0.06% 183
2021
Q1
$3.47M Sell
95,724
-37,143
-28% -$1.32M 0.22% 100
2020
Q4
$4.89M Sell
132,867
-61,171
-32% -$2.24M 0.33% 76
2020
Q3
$6.76M Sell
194,038
-2,962
-2% -$104K 0.4% 68
2020
Q2
$6.11M Buy
197,000
+17,212
+10% +$585K 0.39% 74
2020
Q1
$5.57M Buy
179,788
+4,949
+3% +$169K 0.41% 78
2019
Q4
$6.5M Buy
+174,839
New +$6.23M 0.41% 77
2019
Q2
$7.66M Sell
186,307
-718
-0.4% -$28.5K 0.53% 60
2019
Q1
$7.54M Sell
187,025
-15,672
-8% -$628K 0.54% 61
2018
Q4
$8.39M Buy
202,697
+10,445
+5% +$434K 0.66% 46
2018
Q3
$8.04M Buy
+192,252
New +$7.4M 0.55% 56
2018
Q1
$6.43M Buy
190,930
+2,995
+2% +$103K 0.49% 62
2017
Q4
$6.46M Buy
187,935
+5,403
+3% +$184K 0.49% 65
2017
Q3
$6.18M Sell
182,532
-3,858
-2% -$124K 0.47% 63
2017
Q2
$5.94M Sell
186,390
-18,885
-9% -$596K 0.47% 63
2017
Q1
$6.66M Buy
205,275
+13,311
+7% +$420K 0.54% 50
2016
Q4
$5.92M Buy
191,964
+10,610
+6% +$324K 0.5% 54
2016
Q3
$5.83M Buy
181,354
+13,776
+8% +$461K 0.53% 43
2016
Q2
$5.6M Buy
167,578
+17,707
+12% +$565K 0.54% 41
2016
Q1
$4.21M Buy
149,871
+7,744
+5% +$221K 0.42% 53
2015
Q4
$4.35M Buy
142,127
+5,943
+4% +$187K 0.44% 51
2015
Q3
$4.06M Buy
136,184
+12,330
+10% +$395K 0.45% 50
2015
Q2
$3.94M Sell
123,854
-1,402
-1% -$45.7K 0.39% 58
2015
Q1
$4.13M Buy
125,256
+1,757
+1% +$55.9K 0.41% 57
2014
Q4
$3.65M Buy
123,499
+779
+0.6% +$22.3K 0.39% 62
2014
Q3
$3.44M Buy
122,720
+6,008
+5% +$169K 0.37% 61
2014
Q2
$3.29M Buy
116,712
+2,115
+2% +$60.3K 0.35% 65
2014
Q1
$3.49M Buy
114,597
+91,783
+402% +$2.74M 0.39% 59
2013
Q4
$663K Buy
22,814
+264
+1% +$7.68K 0.08% 103
2013
Q3
$615K Hold
22,550
0.08% 104
2013
Q2
$599K Buy
+22,550
New +$623K 0.08% 101

Other funds holding PFE

First American Bank's PFE Position: Q2 2026 in Review

First American Bank reduced its Pfizer (PFE) stake by 0.29% in Q2 2026, selling an estimated $1.75K and leaving 23,110 shares worth $556K. The position accounts for 0.03% of the portfolio, ranked #168.

First American Bank first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.39M in Q4 2018. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • First American Bank held 23,110 shares of Pfizer worth $556K as of Q2 2026.
  • First American Bank sold 67 Pfizer shares in Q2 2026, an estimated $1.75K.
  • Pfizer made up 0.03% of First American Bank's portfolio in Q2 2026, its #168 holding.
  • First American Bank first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • First American Bank's Pfizer position peaked at $8.39M in Q4 2018.
  • 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.